Your browser doesn't support javascript.
loading
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.
Ochi, Shinichiro; Tagata, Hiromi; Hasegawa, Naomi; Yasui-Furukori, Norio; Iga, Jun-Ichi; Kashiwagi, Hiroko; Kodaka, Fumitoshi; Komatsu, Hiroshi; Tsuboi, Takashi; Tokutani, Akira; Numata, Shusuke; Ichihashi, Kayo; Onitsuka, Toshiaki; Muraoka, Hiroyuki; Iida, Hitoshi; Ohi, Kazutaka; Atake, Kiyokazu; Kishimoto, Taishiro; Hori, Hikaru; Takaesu, Yoshikazu; Takeshima, Masahiro; Usami, Masahide; Makinodan, Manabu; Hashimoto, Naoki; Fujimoto, Michiko; Furihata, Ryuji; Nagasawa, Tatsuya; Yamada, Hisashi; Matsumoto, Junya; Miura, Kenichiro; Kido, Mikio; Hishimoto, Akitoyo; Ueno, Shu-Ichi; Watanabe, Koichiro; Inada, Ken; Hashimoto, Ryota.
Afiliação
  • Ochi S; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Tagata H; Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.
  • Hasegawa N; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Yasui-Furukori N; Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Iga JI; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Kashiwagi H; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Kodaka F; Department of Forensic Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Komatsu H; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japsan.
  • Tsuboi T; Department of Psychiatry, Tohoku University Hospital, Miyagi, Japan.
  • Tokutani A; Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
  • Numata S; Department of Pharmacy, The Hospital of Hyogo College of Medicine, Hyogo, Japan.
  • Ichihashi K; Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
  • Onitsuka T; Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan.
  • Muraoka H; Department of Neuroimaging Psychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Iida H; Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
  • Ohi K; Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Atake K; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Kishimoto T; Nippon Telegraph and Telephone West Corporation Kyushu Health Administration Center, Fukuoka, Japan.
  • Hori H; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
  • Takaesu Y; Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Takeshima M; Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Usami M; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
  • Makinodan M; Department of Child and Adolescent Psychiatry, Kohnodai Hospital, National Center for Global Health and Medicine, Chiba, Japan.
  • Hashimoto N; Department of Psychiatry, Nara Medical University School of Medicine, Nara, Japan.
  • Fujimoto M; Department of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.
  • Furihata R; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Nagasawa T; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yamada H; Kyoto University Health Service, Kyoto, Japan.
  • Matsumoto J; Department of NeuroPsychiatry Kanazawa Medical University, Ishikawa, Japan.
  • Miura K; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Kido M; Department of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan.
  • Hishimoto A; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Ueno SI; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Watanabe K; Toyama City Hospital, Toyama, Japan.
  • Inada K; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
  • Hashimoto R; Department of Psychiatry, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Int J Neuropsychopharmacol ; 25(10): 818-826, 2022 10 25.
Article em En | MEDLINE | ID: mdl-35723038
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Neuropsychopharmacol Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Neuropsychopharmacol Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão